Leukeran Tablet
Chlorambucil
2mg
Excella, Germany
| Pack size | 25's pack |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 45.48 AED |
Indications
Leukeran Tablet is used for:
Chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, hodgkin’s disease
Adult Dose
Oral
Tablet
The usual oral dosage is 0.1 to 0.2 mg/kg body weight daily for 3 to 6 weeks as required.
This usually amounts to 4 to 10 mg per day for the average patient. The entire daily dose may be given at one time. These dosages are for initiation of therapy or for short courses of treatment.
Chronic Lymphatic (Lymphocytic) Leukemia
0.1 mg/kg/day for 3-6 weeks or
0.4 mg/kg (increased by 0.1 mg/kg/dose until response/toxicity observed) biweekly or
0.4 mg/kg (increased by 0.1 mg/kg/dose until response observed) monthly or
0.03-0.1 mg/kg/day continuously
Reduce initial dose if administered within 4 weeks after a full course of radiation/myelosuppressive therapy or patients with bone marrow disease
Not to exceed 0.1 mg/kg/day if bone marrow infiltrated with lymphocytes
Hodgkin's Lymphoma
0.2 mg/kg/day for 3-6 weeks or
0.4 mg/kg (increased by 0.1 mg/kg/dose until response/toxicity observed) biweekly or
0.4 mg/kg (increased by 0.1 mg/kg/dose until response or toxicity observed) monthly or
0.03-0.1 mg/kg/day continuously
Reduce initial dose if administered within 4 weeks after a full course of radiation/myelosuppressive therapy or patients with bone marrow disease
Not to exceed 0.1 mg/kg/day if bone marrow infiltrated with lymphocytes
Child Dose
Renal Dose
Renal Impairment
<1% (including metabolites) excreted in urine; no dose adjustment required
Administration
Should be taken on an empty stomach. Take on an empty stomach. Ensure adequate hydration. Swallow whole, do not chew/crush.
Contra Indications
Hypersensitivity or resistance; demonstrated resistance to chlorambucil previously
Precautions
Severe bone marrow suppression can occur with chlorambucil
Chlorambucil is a carcinogen. Chronic therapy may produce myelocytic leukemia and secondary malignancies
Chlorambucil may cause infertility. It is teratogenic and mutagenic
History of seizures; head trauma; those receiving other potentially epileptogenic drugs
Potentially mutagenic, carcinogenic & teratogenic; avoid pregnancy
Can cause infertility
Severely myelosuppressive
May need lower dosages in liver failure
Beware of cross-hypersensitivity w/ other alkylating agents
Reduce dose in preexisting myelosuppressive situations or if WBC/Plt counts fall below normal
If used within 4 week of radiation/cytotoxic chemotherapy
Avoid pregnancy
Pregnancy-Lactation
Pregnancy Category: D
Lactation: not known if excreted in breast milk; do not nurse
Interactions
Impairs immune response to vaccines, possible infection after admin of live vaccines.
Contraindicated (1)
gepirone
Serious (13)
adenovirus types 4 and 7 live, oral
axicabtagene ciloleucel
brexucabtagene autoleucel
ciltacabtagene autoleucel
etrasimod
idecabtagene vicleucel
influenza virus vaccine quadrivalent, adjuvanted
influenza virus vaccine trivalent, adjuvanted
lisocabtagene maraleucel
palifermin
ropeginterferon alfa 2b
tisagenlecleucel
tofacitinib
Adverse Effects
Side effects of Chlorambucil :
>10%
Neutropenia (25-33%),Anemia,Leukopenia,Thrombocytopenia
Frequency Not Defined
Seizures,Hallucinations,Peripheral neuropathy,Nausea,Vomiting,Pulmonary fibrosis,GI effects,Leukemia,Myelosuppression,Hyperuricemia,Infertility,Hepatotoxicity & jaundice,Type I hypersensitivity,Rash,Stevens-Johnson syndrome (rare),Toxic epidermal necrosis (rare),Urticaria,Erythema multiforme (rare),Secondary malignancies
Potentially Fatal: Severe bone marrow suppression, carcinogenic and human infertility.
Mechanism of Action
Chlorambucil interferes with DNA replication and RNA transcription by alkylation and cross-linking cellular DNA strands, thus leading to disruption of the nucleic acid function.
Note
Leukeran 2mg Tablet manufactured by Excella, Germany. Its generic name is Chlorambucil. Leukeran is availble in Bangladesh.
Farmaco BD drug index information on Leukeran Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.